| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.234 | 10.924 | 172.664 | 168.198 | - | - |
| Total Income - EUR | - | - | - | - | 2.234 | 10.924 | 173.940 | 168.219 | - | - |
| Total Expenses - EUR | - | - | - | - | 3.836 | 7.939 | 155.877 | 156.293 | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | -1.602 | 2.985 | 18.063 | 11.926 | - | - |
| Net Profit/Loss - EUR | - | - | - | - | -1.669 | 2.678 | 16.185 | 9.647 | - | - |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | - | - |
Check the financial reports for the company - Nova Line M.d.m. S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 461 | 627 | - | - |
| Current Assets | - | - | - | - | 1.876 | 2.165 | 19.821 | 47.084 | - | - |
| Inventories | - | - | - | - | 86 | 64 | 15.044 | 23.098 | - | - |
| Receivables | - | - | - | - | 1.782 | 0 | 3.976 | 2.886 | - | - |
| Cash | - | - | - | - | 8 | 2.101 | 800 | 21.101 | - | - |
| Shareholders Funds | - | - | - | - | -1.564 | 1.144 | 17.303 | 24.378 | - | - |
| Social Capital | - | - | - | - | 105 | 103 | 101 | 101 | - | - |
| Debts | - | - | - | - | 3.440 | 1.021 | 2.978 | 23.333 | - | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Nova Line M.d.m. S.r.l.